Oxidative damage in an experimentally induced gastric and gastroduodenal reflux model

Surgical Innovation

Volumn 12, Issue 3, 2005, Pages 219-225

  Erbil, Yesim ^a   Türkoglu, Umit ^a   Barbaros, Umut ^a   Balik, Emre ^a   Olgac, Vakur ^a   Kaya, Hakan ^a   Cimşit, Bayindir ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Gastroesophageal reflux; Oxidative damage; Ulcer

Indexed keywords

CARBONYL DERIVATIVE; CELL DNA; FREE RADICAL; MALONALDEHYDE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE REFLUX; CELL REGENERATION; CONTROLLED STUDY; DNA DAMAGE; DUODENOGASTRIC REFLUX; ESOPHAGUS MUCOSA; ESOPHAGUS ULCER; HISTOPATHOLOGY; LYMPHOCYTE; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRECANCER; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION;

ANIMALS; ANIMALS, NEWBORN; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; DNA DAMAGE; ESOPHAGITIS, PEPTIC; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; IMMUNOHISTOCHEMISTRY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROBABILITY; PROTEIN CARBONYLATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 27744479515     PISSN: 15533506     EISSN: None     Source Type: Journal    
DOI: 10.1177/155335060501200306     Document Type: Article

References (41)

1. Botterweck AA, Schouten LJ, Volovics A: Trends in incidence of adenocarcinoma of the esophagus and gastric cardia in ten European countries. Int J Epidemol 29: 645-654, 2000.
2. Öberg S, Lord RV, Peters JH, et al: Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced? J Surg Res 91:111-917, 2000.
3. Pera M, Cameron AJ, Trastek VF: Increased incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104:510-513, 1993.
4. Cameron AJ, Arora AS: Barrett's esophagus and reflux esophagitis: is there a missing link? Am J Gastroenterol 97:273-278, 2002.
5. Carton E, Caldwell MTP, Mc Donald G, et al: Specialized intestinal metaplasia in patients with gastroesophageal reflux disease. Br J Surg 87:116-21, 2000.
6. Barret NR: Chronic peptic ulcer of esophagus and "esophagitis". Br J Surg 38:175-182, 1950.
7. Cameron AJ, Souto EO, Smyrk TC: Small adenocarcinoma. of esophagogastric junction: association with intestinal metaplasia and dysplasia. Am J Gastroenterol 97:1375-1380, 2002.
8. Farhadi A, Fields J, Banan A, et al: Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's Esophagus and the latter's progression toward esophageal cancer? Am J Gastroenterol 97:21-27, 2002.
9. Goldstein SR, Yang GY, Curtis SK, et al: Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of carcinogen. Carcinogenesis 18:2265-2270, 1997.
10. Sampliner RE, Camargo L, Fass R: Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. Am J Gastroenterol 97:270-272, 2002.
11. Seto Y, and Kobori O: Role of reflux oesephagitis and acid in the development of columnar epithelium in the rat oesophagus. Br J Surg 80:467-70, 1993.
12. Katada NK, Hinder RA, Smyrk TC, et al: Duodenoesophageal reflux induces apoptosis in rat esophageal epithelium. Dig Dis Sci 44:301-310, 1999.
13. Vaezi MF, Richter JE: Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111:1192-1199, 1996.
14. Chen X, Ding YW, Yang G, et al: Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 21:257-263, 2000.
15. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. Oxford: Oxford University Press, 1998.
16. Lee JS, Oh TY, Ahn BO, et al: Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutation Res 480:189-200, 2001.
17. Attwood SE, Smyrk TC, DeMeester TR, et al: Duodenoesophageal reflux and the development of esophageal adenocarcinoma. in rats. Surgery 111:503-510, 1992.
18. Chen X, Yang G, Ding WY, et al: An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 20:1801-1817, 1999.
19. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol 52:302-310, 1972.
20. Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay method. Methods Enzymol 233:357-63, 1994.
21. Duthie SJ, Collins AR: The influence of cell growth, detoxifying enzymes and DNA repair on hydrogen peroxide-mediated DNA damage in human cells. Free Radic Biol Med 22:717-724, 1997.
22. Falk GW: Barrett's esophagus. Gastroenterology 122:1569-1591, 2002.
23. Dixon MF, Neville PM, Mapstone NP, et al: Bile reflux gastritis and Barrett's esophagus: further evidence of a role for duodenogastro-esophageal reflux? Gut 49:359-363, 2001.
24. Ransford RA, Jankowski JA: Genetic versus environmental interactions in the esophagitis-metaplasia-dysplasia-adenocarcinoma sequence (MCS) of Barrett's esophagus. Acta Gastroenterol Belg 63:18-21, 2000.
25. D'Odorico A, Bortolan R, Cardin R, et al: Reduced plasma antioxidant concenrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36:1289-1294, 2001.
26. Oh TY, Lee JS, Alm BO, et al: Oxidative stress is more important than acid in the pathogenesis of reflux esophagitis in rats. Gut 49:364-371, 2001.
27. Qureshi, Gorey TF, Byme P: Oxygen free radical activity in experimental colonic carcinoma. Br J Surg 81:1058-1059, 1994.
28. Olyaee M, Sontag S, Salman W: Mucosal reactive oxygen species production in esophagitis and Barrett's esophagus. Gut 37:168-173, 1995.
29. Wetscher GJ, Hinder RA, Bagchi D: Reflux esophagitis is mediated by oxygen-derived free radicals. Am J Surg 170:552-556.
30. Sihvo EIT, Salminen JT, Rantanen TK, et al: Oxidative stress has a role in malignant transformation in Barrett's esophagus. Int J Cancer 102:551-555, 2002.
31. Miwa K, Sahara H, Segawa M, et al: Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67:269-274, 1996.
32. Pera M, Brito MJ, Poulsom R, et al: Duodenal content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis 21:1587-1591, 2000.
33. Shaheen N, Ransohoff DF: Gastroesophageal reflux, Barrett's esophagus and esophageal cancer: scientific review. JAMA 287:1982-1986, 2002.
34. Buttar NS, Wang KK, Leontovich O, et al: Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 122:1101-1112, 2002.
35. Castel DO, Katzka DA: Importance of adequate acid suppression in the management of Barrett's esophagus. Gastroenterology 117:1509-1510, 1999.
36. Gerson LB, Shetler K, Triadafilopoulos G: Prevalance of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123:461-467, 2002.
37. Immanuel A, Lamb PJ, Wayman J, et al: Prevention of the neoplastic progression of Barrett's esophagus by argon beam plasma ablation. Br J Surg 88:1357-1362, 2001.
38. Fein M, Peters JH, Chandrasoma P, et al: Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 2:260-268, 1998.
39. Ramakrishnan A, Katz PO: Pharmacologic management of GERD. Curr Gastroenterol Rep 4:218-224, 2002.
40. Tselepis C, Perry I, Jankowski J: Barrett's esophagus: Disregulation of cell cycling and intercellular adhesion in the metaplasia-dysplasia-carcinoma sequence. Digestion 61:1-5, 2000.
41. Wetscher GJ, Hinder RA, Klingler P: Reflux esophagitis in human is a free radical event. Dis Esophagus 10:29-32, 1997.